We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Retinal Nerve Fibres Layers Thickness Study in Glaucomatous Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01254006
First Posted: December 6, 2010
Last Update Posted: December 6, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
vingolo enzo maria
domanico daniela
salvatore serena
Information provided by:
University of Roma La Sapienza
November 29, 2010
December 6, 2010
December 6, 2010
Not Provided
Not Provided
retinal nerve fibres layer thickness
Same as current
No Changes Posted
global risk threshold for glaucoma progression
Same as current
Not Provided
Not Provided
 
Retinal Nerve Fibres Layers Thickness Study in Glaucomatous Patients
Not Provided
In this study the investigators are going to study the retinal nerve fibers layers (RNFL) modification of two groups of patients, one taking no drugs, the other taking forskolin, rutin and vitamins B1 and B2.
Not Provided
Interventional
Not Provided
Not Provided
Glaucoma
Drug: forskolin, rutin and vitamins B1 and B2
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Age (30-80 years);
  • Baseline Intraocular pressure (IOP) (20-32 mmHg): average untreated Intra Ocular Pressure (IOP) for both eyes as determined from 2 to 4 visits within a 6-months period;
  • Central Corneal Thickness (CCT) (475-650 µm): average of 3 different measurements from both eyes during the same visit;
  • Pattern standard deviation (PSD) (0,50-3,00 dB) average of both eyes as stated on the most recent visual field index report
  • Vertical Cup/Disk ratio (0,00-0,80): average of both eyes
  • All these data were entered into a calculator specially designed for STAR (Scoring Tool for assessing risk) II parameter. The patients were divided into low-, moderate- and high risk groups according to the result given by the calculator.

Exclusion Criteria:

-other ocular pathologies than glaucoma

Sexes Eligible for Study: All
30 Years to 80 Years   (Adult, Senior)
Not Provided
Contact information is only displayed when the study is recruiting subjects
Italy
 
 
NCT01254006
GLA0110
Not Provided
Not Provided
Not Provided
Not Provided
University of Roma La Sapienza
  • vingolo enzo maria
  • domanico daniela
  • salvatore serena
Not Provided
University of Roma La Sapienza
August 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP